POLARAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Polaramine patents expire, and when can generic versions of Polaramine launch?
Polaramine is a drug marketed by Schering and is included in two NDAs.
The generic ingredient in POLARAMINE is dexchlorpheniramine maleate. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dexchlorpheniramine maleate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for POLARAMINE?
- What are the global sales for POLARAMINE?
- What is Average Wholesale Price for POLARAMINE?
Summary for POLARAMINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 60 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,472 |
| DailyMed Link: | POLARAMINE at DailyMed |
Recent Clinical Trials for POLARAMINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University Hospital, Bordeaux | Phase 3 |
US Patents and Regulatory Information for POLARAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | POLARAMINE | dexchlorpheniramine maleate | SYRUP;ORAL | 086837-001 | Jul 19, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Schering | POLARAMINE | dexchlorpheniramine maleate | TABLET;ORAL | 086835-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
